Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

US: Utah Cannabinoid Product Board takes a stance on delta-8 THC

Patient advocates and some Utah pharmacists have been raising awareness about cannabis products containing delta-8 THC due to its potential health effects.

After listening to researchers and reviewing literature on the matter, the Utah Cannabinoid Product Board voted unanimously to take a stance against analog cannabinoids.

Dr. Perry Fine, chair of the board, said “at this time, there is no evidence of therapeutic benefit of the analog derived synthesized cannabinoids, including delta-8 THC.”

“Risks have been described by federal regulatory bodies and peer reviewed publications regarding delta-8 THC,” Fine said. “At this time, we do not support any therapeutic uses of analog cannabis products.”

To read the complete article, go to www.kuer.org